Ticlatone

This classification denotes a drug therapy and thiazole with the molecular formula C7H4ClNOS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BHW384Q9GI, chemically known as 1,2-benzisothiazolin-3-one, 6-chloro- but generally known as ticlatone, which bears US NIH Compound Identifier 6258. European Medicines Agency schedules Ticlatone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11027MIG. World Health Organization schedules ticlatone in its Anatomical Therapeutic Chemical (ATC) Classification. TICLATONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ticlatone under HS 29349990 and SITC 51579. As of Q4 2014, TICLATONE remains the US FDA Preferred Term for this commodity. SMILES: CLC1CC2S[NH]C(=O)C2CC1.